Tau inclusions are a pathological hallmark defining over 20 neurodegenerative diseases including Alzheimer’s disease (AD), corticobasal degeneration (CBD), and hereditary frontotemporal dementia with parkinsonism-17 (FTDP-17), collectively classified as tauopathies (1). This evidence concerns the gene MAPT and Alzheimer disease.